Best Butterfly Needles in the United States: BD, Greiner Bio-One, and Terumo Compared
Summary
- BD Vacutainer Safety-Lok, Greiner Bio-One Visio Plus, and Terumo SurGuard are among the most established butterfly needle families available to United States healthcare purchasers.
- Reliability depends on more than brand recognition: buyers should evaluate safety activation, needle performance, tubing and connector quality, lot consistency, regulatory documentation, and compatibility with their collection systems.
- Hospitals, laboratories, physician practices, and mobile providers should compare total cost, product availability, staff Training Requirements, recall history, and performance data before selecting a butterfly needle.
Butterfly needles, also called winged blood collection sets or winged infusion sets, are widely used in hospitals, outpatient laboratories, physician offices, urgent-care clinics, home healthcare, blood-draw services, and Mobile Phlebotomy programs. Their short needle, flexible tubing, and winged grips can make Venipuncture easier when veins are small, fragile, superficial, or difficult to access with a straight needle.
However, selecting a dependable butterfly needle is more complicated than choosing the most recognizable brand. A reliable product must support accurate specimen collection, minimize accidental needlestick exposure, maintain a secure connection with collection tubes or syringes, and perform consistently across different patients and users. Procurement teams must also consider FDA requirements, Occupational Safety and Health Administration standards, distributor availability, product recalls, and the total cost of using the device.
In the United States, several manufacturers have developed strong reputations in blood collection and safety-engineered needles. The most commonly evaluated product families include BD Vacutainer Safety-Lok, Greiner Bio-One Visio Plus, Terumo SurGuard, and selected products from Nipro, Cardinal Health, Medline, McKesson, and Exel International. Reliability is not identical across every model, gauge, tubing length, or safety configuration, so purchasing decisions should be based on the exact catalog number rather than the brand name alone.
What Makes a Butterfly Needle Reliable?
Reliability in phlebotomy has several dimensions. A needle can be sharp and easy to insert but still be a poor choice if its safety mechanism is difficult to activate. Similarly, an inexpensive set may appear attractive until a high rate of failed draws, redraws, blood leakage, or discarded supplies increases the actual cost per successful specimen.
Needle sharpness and geometry
Sharpness is one of the first characteristics noticed by a phlebotomist. A well-manufactured needle should penetrate the skin smoothly and produce minimal drag. Bevel geometry, siliconization, cannula quality, and manufacturing tolerances all influence insertion performance. A sharp needle can reduce patient discomfort and may help the collector maintain control during Venipuncture.
Needle Gauge also matters. Common butterfly sizes include 21-gauge, 23-gauge, and 25-gauge, although availability varies by manufacturer. A 21-gauge set may support faster blood flow for routine adult collections, while a 23-gauge set is frequently selected for smaller or more fragile veins. A 25-gauge set may be useful in selected situations, but smaller internal diameters can increase the risk of hemolysis or prolonged collection if the draw technique and tube-filling sequence are not appropriate.
Safety activation
Safety-engineered butterfly needles are designed to reduce exposure to contaminated sharps. The safety feature may be activated by sliding, pressing, or otherwise engaging a shield after the needle is removed from the patient. The best systems allow activation with one hand, provide a clear tactile or audible indication, and reduce the likelihood that the user must bring a hand near the exposed needle.
Under the federal Needlestick Safety and Prevention Act and OSHA’s Bloodborne Pathogens Standard, employers must use engineering controls where feasible and evaluate safer devices with input from affected healthcare workers. A safety device that is technically compliant but difficult to operate may not provide the same practical protection as a product that staff can activate quickly and consistently.
Tubing, wings, and connectors
The flexible tubing should resist kinking while remaining easy to control. Excessively rigid tubing can pull on the needle or patient’s skin, while tubing that is too soft may collapse or kink during collection. Wings should provide a stable grip and should not separate from the needle hub during normal use.
Most blood collection sets use a luer connection, allowing attachment to a tube holder, syringe, or other compatible collection equipment. Buyers should verify whether the product includes a preattached holder, a luer adapter, or neither. A lower-priced needle that requires separate holders or adapters may not be less expensive after all components are included.
Specimen quality
A butterfly set is part of the preanalytical process, which includes patient identification, site preparation, Venipuncture, tube order, mixing, transport, and processing. A needle alone does not determine specimen quality, but its design can contribute to hemolysis, clotting, underfilled tubes, or delays in reaching the laboratory.
Institutions should monitor rejected specimens by collection device, location, shift, and operator where practical. Useful indicators include hemolysis rates, recollection rates, clotted specimens, Blood Culture contamination, patient complaints, needlestick incidents, and safety-mechanism failures. These local data are often more useful than general marketing claims.
BD Vacutainer Safety-Lok
BD is one of the most established medical technology companies in the United States, and its Vacutainer product family is widely recognized in blood collection. The BD Vacutainer Safety-Lok blood collection set is commonly considered a leading option for hospitals, reference laboratories, outpatient draw centers, and large physician networks.
The product family is known for integrating a winged needle, flexible tubing, and a safety mechanism intended to shield the needle after use. Depending on the model, purchasers may select different needle gauges, tubing lengths, and connector configurations. Some facilities prefer a version with a preattached holder, while others use a luer-compatible design that fits existing collection systems.
Why purchasers consider BD reliable
- BD has extensive experience in evacuated blood collection systems and safety-engineered devices.
- The Vacutainer name is familiar to many phlebotomists, which can reduce training time when a facility already uses other BD collection products.
- Product documentation, packaging controls, and distribution coverage are generally strong in the United States.
- Large healthcare systems may benefit from standardized ordering, contract pricing, and broad distributor availability.
- The product is offered in configurations suitable for routine adult draws and selected difficult-access applications.
One advantage of selecting a widely used system is operational familiarity. A hospital that already uses BD evacuated tubes may find it easier to standardize tube holders, training materials, and supply cabinets. Standardization can reduce picking errors and help staff recognize compatible components.
Potential disadvantages include a higher purchase price than some generic or private-label alternatives. Availability can also differ by specific gauge and tubing length. A facility should not assume that all BD butterfly needles are interchangeable; the purchasing department should confirm the exact product number, safety mechanism, connector, sterility status, and packaging quantity.
Greiner Bio-One Visio Plus
Greiner Bio-One is a major international supplier of blood collection products, and its United States operations serve hospitals, laboratories, and other healthcare organizations. The Greiner Bio-One Visio Plus safety blood collection set is frequently evaluated alongside BD products, particularly by organizations using Greiner evacuated tubes or seeking a competing safety-engineered option.
Greiner’s blood collection portfolio is associated with the VACUETTE system. Visio Plus sets are designed for controlled blood collection through a winged needle and flexible tubing. Depending on configuration, the set may be used with a tube holder or other compatible components.
Why purchasers consider Greiner reliable
- Greiner Bio-One has a substantial presence in laboratory and blood collection products.
- The company offers a broad range of blood collection components, which can support system-wide standardization.
- Its safety sets are familiar to many laboratories and outpatient collection services.
- Organizations may find competitive pricing when comparing Greiner with other major manufacturers.
- Facilities using VACUETTE tubes may be able to simplify training and supply management by keeping collection products within one system.
Greiner products can be particularly attractive when a laboratory has already validated VACUETTE tubes and related accessories. The purchasing department should nevertheless conduct its own evaluation of fill volumes, tube compatibility, holder fit, safety activation, and specimen quality.
As with all brands, performance depends on the exact model. A product intended for standard Venipuncture may not be the best choice for pediatric, geriatric, oncology, or home-care applications. Buyers should request samples and obtain feedback from phlebotomists who routinely collect from the patient populations involved.
Terumo SurGuard
Terumo is another well-established medical device manufacturer with a significant presence in needles, syringes, blood collection, and safety products. The SurGuard family includes safety-engineered needles and blood collection sets used in various healthcare environments.
Terumo’s reputation is supported by long experience in needle manufacturing and injection technology. Many purchasing teams include SurGuard in competitive evaluations when they want to compare needle sharpness, safety activation, tubing flexibility, and overall user experience against BD and Greiner products.
Why purchasers consider Terumo reliable
- Terumo has extensive manufacturing experience with needles and other blood-access devices.
- SurGuard products are designed around needlestick prevention and safety activation.
- The company provides product options for different collection settings and user preferences.
- Terumo may offer a useful alternative when a facility wants to diversify its supplier base.
- Phlebotomy teams often evaluate Terumo products favorably for insertion feel and device handling, although results vary by individual model and user.
Supplier diversification can be valuable for large healthcare organizations. Relying on only one manufacturer may create operational risk if a factory disruption, allocation, transportation problem, or unexpected recall affects supply. A facility may qualify a secondary product such as Terumo SurGuard while retaining its primary product for routine use.
Before switching, the organization should verify that the safety mechanism is intuitive for all shifts and locations. A product that works well in a controlled laboratory environment may require additional coaching in emergency departments, inpatient units, or mobile settings where staff have less time and equipment may be stored differently.
Other Brands and Private-Label Options
BD, Greiner Bio-One, and Terumo are often the first brands considered for large-scale procurement, but they are not the only options. Nipro, Cardinal Health, Medline, McKesson, and Exel International may offer safety blood collection sets or related winged needle products through United States distribution channels. Some products are manufactured under a private label or supplied through a contract manufacturing arrangement.
Private-label products can offer meaningful savings, especially for physician offices, independent laboratories, and outpatient clinics with predictable demand. However, buyers should apply the same technical review used for a national brand. A lower price does not automatically indicate lower quality, and a familiar distributor name does not necessarily identify the original manufacturer.
Questions to ask about lesser-known or private-label products
- Who is the legal manufacturer and where is the product manufactured?
- Is the device cleared or otherwise appropriately listed with the FDA for its intended use?
- Does the manufacturer provide a UDI, lot number, expiration date, and traceability information?
- What quality management standard is used, such as ISO 13485?
- What inspection and complaint-handling process is used for production lots?
- Are certificates of analysis, sterilization records, or conformity documents available when needed?
- How does the manufacturer notify customers about recalls, field corrections, or supply interruptions?
- Can the supplier provide samples for staff evaluation before a full conversion?
- What is the expected lead time during normal demand and during a shortage?
- Are replacement products offered if the exact gauge, tubing length, or connector becomes unavailable?
Product traceability is especially important for facilities with multiple locations. The organization should be able to identify which lots were delivered to which departments and which patients may have been affected if a safety notice is issued.
Important United States Regulations and Standards
Purchasing decisions should align with federal and state requirements. The FDA regulates medical devices, and manufacturers are responsible for complying with applicable requirements for their products. The FDA’s Unique Device Identification system is intended to improve the ability to identify devices used in healthcare and support more efficient recall management.
OSHA’s Bloodborne Pathogens Standard requires employers with occupational exposure to blood or other potentially infectious materials to maintain an exposure control plan, use appropriate engineering and work-practice controls, and provide training and protective equipment. OSHA also requires employers to consider safer medical devices and document input from frontline employees.
The CDC and the National Institute for Occupational Safety and Health have repeatedly emphasized the importance of sharps injury prevention, safe disposal, and appropriate training. Older occupational safety estimates have commonly cited hundreds of thousands of percutaneous injuries among hospital workers in the United States each year, with one frequently referenced estimate placing hospital Needlestick Injuries at approximately 385,000 annually. The exact number is difficult to establish because reporting practices differ and injuries in outpatient, long-term-care, home-health, and laboratory settings may be undercounted.
These figures should not be interpreted as a performance ranking for any particular butterfly needle. Public injury statistics generally do not provide a reliable denominator for comparing one brand with another. They do, however, demonstrate why safety activation, training, disposal, and post-exposure procedures deserve serious attention during procurement.
How to Compare Butterfly Needle Brands
A structured evaluation is more reliable than selecting a product solely because another facility uses it. A purchasing committee should include phlebotomists, nurses, laboratory professionals, infection prevention staff, occupational health representatives, supply-chain personnel, and, when appropriate, clinicians who manage difficult-access patients.
1. Define the intended use
Start by identifying where the butterfly needle will be used. A central hospital laboratory may require large volumes of standard adult collections. An emergency department may need multiple gauges and longer tubing. A pediatric clinic may prioritize small-gauge options and gentle handling. A home healthcare program may value compact packaging, simple safety activation, and reliable shipping more than bulk case pricing.
2. Compare the full specification
Compare Needle Gauge, needle length, tubing length, priming volume, connector type, holder configuration, safety mechanism, sterilization method, expiration period, package size, and storage requirements. A set with longer tubing may be more useful in certain situations but may also have a larger dead space. This can matter when small-volume specimens are collected or when a discard tube is required by the collection protocol.
3. Conduct a hands-on trial
Clinical staff should test the products on models and, under approved conditions, during routine collections. Evaluation forms can rate insertion smoothness, wing grip, tubing control, holder connection, visibility of blood flow, ease of safety activation, and disposal. Staff should also note whether the device creates excessive drag, leaks, or disconnects under normal use.
4. Measure local outcomes
During a trial, track first-attempt success, redraws, hemolysis, clotting, Specimen Rejection, patient discomfort, safety activation failures, and needlestick or blood-exposure events. A trial period of several weeks may provide more useful information than a single demonstration. Results should be adjusted for patient population and collection setting because difficult-access cases can produce different outcomes from routine outpatient draws.
5. Calculate total cost of ownership
The invoice price is only one part of the financial analysis. Total cost may include needle holders, adapters, discard tubes, sharps containers, staff training, storage space, wasted devices, failed collections, recollection labor, specimen transport, and treatment of occupational exposures.
For example, if a product costs 10 cents less per set but produces even a small increase in redraws, the apparent savings may disappear. A practical calculation should include the cost per successful, acceptable specimen rather than the cost per unopened device.
Supply Availability and Procurement Risk
Healthcare supply chains experienced significant disruption during the Covid-19 pandemic, and many organizations learned that a clinically acceptable product is not useful if it cannot be delivered consistently. Butterfly needles are relatively small items, but demand can rise quickly during public health emergencies, seasonal illness, large vaccination programs, or regional distribution problems.
Purchasing departments should review average monthly use, maximum inventory, minimum reorder points, supplier lead time, and available substitutes. Critical-care hospitals may maintain a secondary qualified supplier or approved alternate product. Smaller clinics should avoid purchasing large quantities solely because of a temporary discount if the product could expire before use.
Organizations should also confirm whether the quoted product is regularly stocked in the United States or imported only after an order is placed. Domestic distribution does not necessarily mean domestic manufacturing. The important questions are whether inventory is dependable, whether allocations are communicated promptly, and whether the supplier can provide advance notice of discontinuations or substitutions.
Storage, Expiration, and Quality Control
Sterile butterfly needles should remain in their original packaging until use and should be stored according to the manufacturer’s instructions. Excessive heat, moisture, compression, or damage to packaging can compromise product integrity. Supply rooms should use first-expire, first-out rotation and should remove damaged or expired packages from inventory.
Receiving staff should inspect shipments for crushed cartons, broken seals, missing lot information, incorrect gauge, and unexpected substitutions. For multi-site organizations, a central purchasing office should maintain a current product list and ensure that each location knows which devices are approved.
Any device malfunction should be documented through the organization’s incident-reporting system. Examples include failure of the safety shield to activate, needle separation, tubing leakage, blocked flow, unusual resistance, damaged wings, or missing components. Serious events may require reporting through internal Risk Management and appropriate regulatory channels.
Which Brand Is the Best Choice?
There is no universal winner for every United States purchaser. BD Vacutainer Safety-Lok is often a strong choice for organizations seeking a widely recognized, broadly distributed product with compatibility across a familiar blood collection ecosystem. Greiner Bio-One Visio Plus is a credible alternative for facilities using VACUETTE products or seeking competitive procurement. Terumo SurGuard is another established option, particularly for organizations evaluating needle handling and safety performance from a major needle manufacturer.
Private-label and distributor products may be appropriate when they meet the same technical, regulatory, and clinical requirements at a lower total cost. Their suitability should be demonstrated through documentation and a controlled trial rather than assumed from price alone.
For most purchasers, the most defensible approach is to create a short list of two or three qualified products, test them with frontline staff, review quality and supply information, and compare measured outcomes. The final selection should be based on consistent specimen quality, safe operation, reliable availability, and acceptable total cost.
Recommended Purchasing Checklist
- Identify the patient populations and collection environments where the butterfly needles will be used.
- Specify the required gauges, tubing lengths, connector types, holders, and safety features.
- Confirm the legal manufacturer, FDA status, UDI information, lot traceability, and expiration dating.
- Request samples and conduct a structured clinical evaluation with phlebotomists and nurses.
- Measure first-attempt success, redraws, hemolysis, Specimen Rejection, safety activation, and user satisfaction.
- Review OSHA requirements, the facility exposure-control plan, and frontline employee input.
- Compare total cost per successful specimen instead of unit price alone.
- Evaluate distributor inventory, lead times, allocation policies, substitutions, and recall communication.
- Approve a primary product and, when practical, a qualified secondary product.
- Reassess performance after implementation using incident, quality, and supply-chain data.
Final Considerations
The most reliable butterfly needle is the one that performs consistently for the intended patient population, can be activated safely by the staff who use it, supports acceptable specimen quality, and remains available when needed. Brand reputation is a useful starting point, but it should not replace product-level evaluation.
In the United States, BD Vacutainer Safety-Lok, Greiner Bio-One Visio Plus, and Terumo SurGuard are sensible brands to include in a professional comparison. Nipro, Medline, Cardinal Health, McKesson, Exel International, and other qualified suppliers may also deserve consideration depending on the required specifications and distribution arrangements.
A well-designed purchasing process combines clinical testing, regulatory review, staff feedback, quality data, and supply-chain planning. By evaluating the complete system rather than focusing only on the needle price, healthcare organizations can select butterfly needles that protect workers, improve patient experience, reduce recollections, and support dependable laboratory results.
Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.